Mesa Laboratories Stock Price To Earnings To Growth

MLAB Stock

USD 124.64 2.75 2.26%

Mesa Laboratories fundamentals help investors to digest information that contributes to Mesa Laboratories' financial success or failures. It also enables traders to predict the movement of Mesa Stock. The fundamental analysis module provides a way to measure Mesa Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mesa Laboratories stock.

Other Current Liab Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Mesa Laboratories Company Price To Earnings To Growth Analysis

Mesa Laboratories' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.

PEG Ratio

PE Ratio

EPS Growth

More About Price To Earnings To Growth | All Equity Analysis

Mesa Price To Earnings To Growth Driver Correlations

Understanding the fundamental principles of building solid financial models for Mesa Laboratories is extremely important. It helps to project a fair market value of Mesa Stock properly, considering its historical fundamentals such as Price To Earnings To Growth. Since Mesa Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Mesa Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Mesa Laboratories' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Accounts Payable	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Good Will	Current Deferred Revenue	Long Term Debt	Net Tangible Assets	Deferred Long Term Liab	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.91	0.55	-0.28	0.91	0.92	0.82	0.92	-0.13	0.78	0.93	0.8	0.97	0.87	0.91	0.7	0.8	0.94	0.34	-0.61	0.98	0.71	0.92
Total Stockholder Equity	0.91		0.2	0.1	0.68	0.68	0.83	0.72	0.01	0.63	0.72	0.61	0.85	0.61	0.66	0.74	0.59	0.73	0.03	-0.54	0.93	0.76	0.76
Net Debt	0.55	0.2		-0.73	0.83	0.8	0.1	0.77	-0.42	0.55	0.69	0.7	0.68	0.83	0.79	0.19	0.72	0.74	0.62	-0.38	0.46	-0.07	0.63
Retained Earnings	-0.28	0.1	-0.73		-0.58	-0.61	-0.19	-0.5	0.16	-0.33	-0.61	-0.43	-0.33	-0.69	-0.64	0.0	-0.52	-0.57	-0.77	0.09	-0.24	-0.11	-0.55
Net Receivables	0.91	0.68	0.83	-0.58		0.98	0.61	0.98	-0.23	0.72	0.95	0.87	0.94	0.97	0.97	0.54	0.85	0.97	0.56	-0.59	0.84	0.46	0.92
Total Liab	0.92	0.68	0.8	-0.61	0.98		0.68	0.96	-0.24	0.79	0.97	0.85	0.93	0.97	1.0	0.54	0.87	0.99	0.57	-0.58	0.86	0.54	0.94
Total Current Assets	0.82	0.83	0.1	-0.19	0.61	0.68		0.64	0.13	0.61	0.77	0.56	0.67	0.61	0.69	0.64	0.54	0.74	0.24	-0.48	0.83	0.98	0.78
Accounts Payable	0.92	0.72	0.77	-0.5	0.98	0.96	0.64		-0.22	0.81	0.93	0.86	0.95	0.93	0.95	0.64	0.86	0.94	0.51	-0.64	0.85	0.49	0.9
Short Term Debt	-0.13	0.01	-0.42	0.16	-0.23	-0.24	0.13	-0.22		-0.1	-0.12	-0.41	-0.22	-0.25	-0.23	0.08	-0.31	-0.24	-0.14	0.62	-0.02	0.2	-0.08
Intangible Assets	0.78	0.63	0.55	-0.33	0.72	0.79	0.61	0.81	-0.1		0.72	0.66	0.75	0.71	0.79	0.72	0.67	0.76	0.35	-0.5	0.74	0.51	0.7
Common Stock	0.93	0.72	0.69	-0.61	0.95	0.97	0.77	0.93	-0.12	0.72		0.79	0.91	0.97	0.97	0.57	0.84	0.98	0.56	-0.5	0.9	0.66	0.98
Property Plant Equipment	0.8	0.61	0.7	-0.43	0.87	0.85	0.56	0.86	-0.41	0.66	0.79		0.82	0.82	0.84	0.52	0.77	0.85	0.48	-0.82	0.66	0.4	0.73
Good Will	0.97	0.85	0.68	-0.33	0.94	0.93	0.67	0.95	-0.22	0.75	0.91	0.82		0.9	0.92	0.65	0.83	0.94	0.36	-0.6	0.94	0.53	0.9
Current Deferred Revenue	0.87	0.61	0.83	-0.69	0.97	0.97	0.61	0.93	-0.25	0.71	0.97	0.82	0.9		0.98	0.52	0.86	0.96	0.62	-0.49	0.83	0.47	0.93
Long Term Debt	0.91	0.66	0.79	-0.64	0.97	1.0	0.69	0.95	-0.23	0.79	0.97	0.84	0.92	0.98		0.54	0.86	0.99	0.59	-0.57	0.86	0.56	0.94
Net Tangible Assets	0.7	0.74	0.19	0.0	0.54	0.54	0.64	0.64	0.08	0.72	0.57	0.52	0.65	0.52	0.54		0.33	0.54	0.08	-0.43	0.71	0.58	0.61
Deferred Long Term Liab	0.8	0.59	0.72	-0.52	0.85	0.87	0.54	0.86	-0.31	0.67	0.84	0.77	0.83	0.86	0.86	0.33		0.85	0.5	-0.53	0.73	0.4	0.8
Long Term Debt Total	0.94	0.73	0.74	-0.57	0.97	0.99	0.74	0.94	-0.24	0.76	0.98	0.85	0.94	0.96	0.99	0.54	0.85		0.54	-0.59	0.89	0.61	0.95
Capital Surpluse	0.34	0.03	0.62	-0.77	0.56	0.57	0.24	0.51	-0.14	0.35	0.56	0.48	0.36	0.62	0.59	0.08	0.5	0.54		-0.19	0.28	0.15	0.51
Short Long Term Debt	-0.61	-0.54	-0.38	0.09	-0.59	-0.58	-0.48	-0.64	0.62	-0.5	-0.5	-0.82	-0.6	-0.49	-0.57	-0.43	-0.53	-0.59	-0.19		-0.46	-0.36	-0.48
Net Invested Capital	0.98	0.93	0.46	-0.24	0.84	0.86	0.83	0.85	-0.02	0.74	0.9	0.66	0.94	0.83	0.86	0.71	0.73	0.89	0.28	-0.46		0.74	0.92
Net Working Capital	0.71	0.76	-0.07	-0.11	0.46	0.54	0.98	0.49	0.2	0.51	0.66	0.4	0.53	0.47	0.56	0.58	0.4	0.61	0.15	-0.36	0.74		0.67
Capital Stock	0.92	0.76	0.63	-0.55	0.92	0.94	0.78	0.9	-0.08	0.7	0.98	0.73	0.9	0.93	0.94	0.61	0.8	0.95	0.51	-0.48	0.92	0.67

Click cells to compare fundamentals

Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.

Competition

Predict Mesa Laboratories

Mesa Price Earnings To Growth Ratio

Price Earnings To Growth Ratio

1.03E-4

At present, Mesa Laboratories' Price Earnings To Growth Ratio is projected to drop based on the last few years of reporting.

Based on the latest financial disclosure, Mesa Laboratories has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Life Sciences Tools & Services sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.

Mesa Price To Earnings To Growth Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mesa Laboratories' direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mesa Laboratories could also be used in its relative valuation, which is a method of valuing Mesa Laboratories by comparing valuation metrics of similar companies.

Mesa Laboratories is currently under evaluation in price to earnings to growth category among its peers.

Mesa Laboratories ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Mesa Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Mesa Laboratories' managers, analysts, and investors.

Environmental

Governance

Social

Mesa Fundamentals

	Return On Equity	-0.89
	Return On Asset	0.0218
	Profit Margin	(1.05) %
	Operating Margin	0.09 %
	Current Valuation	857.9 M
	Shares Outstanding	5.43 M
	Shares Owned By Insiders	5.74 %
	Shares Owned By Institutions	95.90 %
	Number Of Shares Shorted	191.67 K
	Price To Earning	433.94 X
	Price To Book	4.36 X
	Price To Sales	2.85 X
	Revenue	216.19 M
	Gross Profit	151.48 M
	EBITDA	(238.38 M)
	Net Income	(254.25 M)
	Cash And Equivalents	43.75 M
	Cash Per Share	8.23 X
	Total Debt	231.3 M
	Debt To Equity	0.57 %
	Current Ratio	2.90 X
	Book Value Per Share	28.57 X
	Cash Flow From Operations	44.13 M
	Short Ratio	5.74 X
	Earnings Per Share	(47.36) X
	Target Price	150.0
	Number Of Employees	736
	Beta	0.82
	Market Capitalization	677.25 M
	Total Asset	446.8 M
	Retained Earnings	(183.49 M)
	Working Capital	65.04 M
	Current Asset	10.74 M
	Current Liabilities	657 K
	Annual Yield	0.01 %
	Five Year Return	0.29 %
	Net Asset	446.8 M
	Last Dividend Paid	0.64

About Mesa Laboratories Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Mesa Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mesa Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mesa Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether Mesa Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesa Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesa Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesa Laboratories Stock:

How To Invest In Mesa

Details

Is Mesa Stock a good investment?

Details

What is Mesa Laboratories' Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Mesa Laboratories Piotroski F Score and Mesa Laboratories Altman Z Score analysis.

For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.

You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesa Laboratories. If investors know Mesa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesa Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

3.875

Dividend Share

0.64

Earnings Share

(47.36)

Revenue Per Share

43.964

Quarterly Revenue Growth

0.175

The market value of Mesa Laboratories is measured differently than its book value, which is the value of Mesa that is recorded on the company's balance sheet. Investors also form their own opinion of Mesa Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Mesa Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesa Laboratories' market value can be influenced by many factors that don't directly affect Mesa Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Mesa Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesa Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesa Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Mesa Laboratories Stock Price To Earnings To Growth

Mesa Laboratories Company Price To Earnings To Growth Analysis

PEG Ratio

PE Ratio

EPS Growth

Mesa Price To Earnings To Growth Driver Correlations

Mesa Price Earnings To Growth Ratio

Price Earnings To Growth Ratio

1.03E-4

Mesa Price To Earnings To Growth Peer Comparison

Mesa Laboratories ESG Sustainability

Mesa Fundamentals

About Mesa Laboratories Fundamental Analysis

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY